3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
4
Leiomyoma
4
Endometrial Neoplasms
4
Ovarian Neoplasms
3
Uterine Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Dysplasia
1
Precancerous Conditions
1
Myofibroma
1
Metrorrhagia
1
Menstruation Disturbances
1
Menorrhagia
1
Hysterectomy
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Endometriosis
1
Endometrial Hyperplasia
1
Disease
1
Carcinoma, Squamous Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Endometrioid
1
Carcinoma, Adenosquamous
1
Adenomyosis
1
Adenocarcinoma
1
Interventions
Saline Solution
2
Bupivacaine
2
ramosetron
1
Uterine Artery Embolization
1
Triamcinolone Acetonide
1
Triamcinolone
1
Salpingectomy
1
Robotic Surgical Procedures
1
Oxytocin
1
Iohexol
1
Indocyanine Green
1
Ibuprofen
1
Hysterectomy
1
High-Energy Shock Waves
1
Gonadotropin-Releasing Hormone
1
Endoscopes
1
Elasticity Imaging Techniques
1
Dexamethasone
1
Ascorbic Acid
1
Anesthesia, Obstetrical
1
Analgesia, Patient-Controlled
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Adenomyosis
×
Hysterectomy
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled